Salarius Pharmaceuticals, Inc.·4

Nov 24, 5:08 PM ET

HANISH ARNOLD C 4

4 · Salarius Pharmaceuticals, Inc. · Filed Nov 24, 2025

Insider Transaction Report

Form 4
Period: 2025-11-20
Transactions
  • Purchase

    Common Stock

    2025-11-20$0.75/sh+5,000$3,7415,015 total(indirect: By Trust)
Holdings
  • Common Stock

    12
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7437 to $0.75, inclusive. The reporting person undertakes to provide to Salarius Pharmaceuticals, Inc., any security holder of Salarius Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file
  • 4
    wk-form4_1764022090.xmlPrimary

    FORM 4